April 12, 2015 | Mylan N.V. has made a $29 billion offer to acquire Irish pharmaceutical company Perrigo at $205 per share. Perrigo, which has two offices in Israel, will delist from the TASE and other stock markets if the deal goes through, with Perrigo being one of the more heavily-traded stocks on the TASE. Perrigo has been operating in Israel and on the TASE since it acquired Agis Pharmaceuticals in March 2005.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments